Abstract:The inward rectifying K+ channel Kir2.1 plays a major role in extracellular potassium buffering in the brain. Here we show that in cellular models of aging neuroglia characterized by an elevated oxidative stress, the Kir2.1‐induced current is dramatically reduced. This loss of function resulted from a reduction in protein abundance, with no alterations in transcript levels and trafficking to the cell surface. Importantly, the antioxidant biofactor melatonin reverted these changes. We suggest that inhibition of Kir2.1 function by oxidative stress might alter the extracellular K+ buffering in the brain, therefore contributing to neuronal hyperexcitability and epileptogenesis during aging. Melatonin can play a protective role in this context. Melatonin is a pleiotropic biofactor and an effective antioxidant and free radical scavenger and, as such, can be protective in oxidative stress‐related brain conditions including epilepsy and aging. To test the potential protective effect of melatonin on brain homeostasis and identify the corresponding molecular targets, we established a new model of oxidative stress‐related aging neuroglia represented by U‐87 MG cells exposed to D‐galactose (D‐Gal). This model was characterized by a substantial elevation of markers of oxidative stress, lipid peroxidation, and protein oxidation. The function of the inward rectifying K+ channel Kir2.1, which was identified as the main Kir channel endogenously expressed in these cells, was dramatically impaired. Kir2.1 was unlikely a direct target of oxidative stress, but the loss of function resulted from a reduction of protein abundance, with no alterations in transcript levels and trafficking to the cell surface. Importantly, melatonin reverted these changes. All findings, including the melatonin antioxidant effect, were reproduced in heterologous expression systems. We conclude that the glial Kir2.1 can be a target of oxidative stress and further suggest that inhibition of its function might alter the extracellular K+ buffering in the brain, therefore contributing to neuronal hyperexcitability and epileptogenesis during aging. Melatonin can play a protective role in this context.

Potassium regulation could be key to healthy brain ageing

Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration

Potassium homeostasis during disease progression of Alzheimers Disease

Long-Term Potentiation is Impaired in Middle-Aged Rats: Regional Specificity and Reversal by Adenosine Receptor Antagonists

Neuromodulation of astrocytic K+ clearance

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice

Amyloid-β Protein Precursor Regulates Electrophysiological Properties in the Hippocampus Via Altered Kv1.4 Expression and Function in Mice

Melatonin protects Kir2.1 function in an oxidative stress‐related model of aging neuroglia

Pathological and functional significance of aging mouse kidneys: clinical implications to reduce the risk of hyper- or hypokalemia in the elderly

Essential conserved neuronal motors kinesin-1 and kinesin-3 regulate Aβ42 toxicity in vivo

Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain

The Neuronal Kinesin UNC-104/KIF1A Is a Key Regulator of Synaptic Aging and Insulin Signaling-Regulated Memory

Overactivation of prefrontal astrocytes impairs cognition through the metabolic pathway of central kynurenines

Microglial activation in CKD-associated cognitive decline

Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model.

Gluk4-containing kainate receptors regulate synaptic communication in the motor cortex and reduce axon degeneration in adult mice

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease

Higher sodium in older individuals or after stroke/reperfusion, but not in migraine or Alzheimer's disease – a study in different preclinical models

Therapeutic role of voltage-gated potassium channels in age-related neurodegenerative diseases